Clinical Trial Update: Fish Oil and Aspirin With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying the effects of fish oil and aspirin in people with type 2 diabetes and cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• Fish oil (omega-3 fatty acids) (omega-3 fatty acids)

Snippet

Sponsor: University of Rochester | Conditions: Cardiovascular Disease | Phase 2 | Status: COMPLETED